Contrasting biote (NASDAQ:BTMD) & Pervasip (OTCMKTS:PVSP)

biote (NASDAQ:BTMD) and Pervasip (OTCMKTS:PVSP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Volatility & Risk

biote has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Pervasip has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500.

Profitability

This table compares biote and Pervasip’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	1.79%	-45.10%	19.61%
Pervasip	-14.89%	N/A	-26.25%

Insider & Institutional Ownership

21.7% of biote shares are held by institutional investors. 13.9% of biote shares are held by company insiders. Comparatively, 9.2% of Pervasip shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares biote and Pervasip’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$185.36 million	2.42	$3.32 million	($0.22)	-27.32
Pervasip	$15.77 million	0.14	-$2.35 million	N/A	N/A

biote has higher revenue and earnings than Pervasip.

Analyst Recommendations

This is a summary of current recommendations and price targets for biote and Pervasip, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	0	0	5	0	3.00
Pervasip	0	0	0	0	N/A

biote currently has a consensus price target of $8.11, indicating a potential upside of 34.94%. Given biote’s higher possible upside, research analysts plainly believe biote is more favorable than Pervasip.

Summary

biote beats Pervasip on 10 of the 11 factors compared between the two stocks.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

About Pervasip

Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.